When Dr. Myra Ahmad founded Mochi Health in 2022, she chose a different path from many health-tech funders. By building the company with minimal outside funding, a largely bootstrapped approach, she was able to focus on sustainable growth, transparent pricing, and patient-centered healthcare.
The standard health-tech playbook is well understood. Raise a large round. Subsidize growth with venture cash. Chase engagement metrics, and figure out the unit economics later.
Dr. Myra Ahmad looked at that playbook when she founded Mochi Health in 2022 and declined it. The company grew to serve more than 500,000 patients on minimal outside funding, achieving cash-flow-positive growth rather than depending on investor funding to cover ongoing losses. Ahmad has been explicit that the choice wasn’t incidental to the mission. It was a condition of protecting it.
“A lot of the capital assumptions don’t lend to the models that actually help patients,” she explained in an interview with Women of Wearables (WoW).
Her read is specific: money raised against growth metrics tends to reward signups and engagement over whether a patient actually got better or stayed in treatment, and a founder answering to that pressure will eventually make decisions the patient relationship can’t survive.
Why Myra Ahmad Rejected the Venture-Capital Playbook
Ahmad’s resistance to outside capital traces back further than Mochi itself. Before founding the company, she had committed to serving patients in a way that traditional healthcare tends to overlook: people without insurance, facing language or cultural barriers, or living in rural communities without easy access to specialists.
She has described watching providers use shame when discussing a patient’s weight, dismiss legitimate medical concerns out of bias, and refuse safe, effective medications in favor of “diet and exercise only” advice that wasn’t working.
A funding structure that rewarded fast growth over patient outcomes could have recreated exactly the dynamic she’d set out to fix.
That’s the frame behind her advice to other founders: “try to get close to the patient problem, and not the business problem.”
Too many people, in her view, enter healthcare with “a solution in search of a problem,” raising money against an idea before they’ve actually sat with the ways patients are being underserved. Bootstrapping a healthcare startup wasn’t just a financing preference for Ahmad. It was a forcing function to stay close to the problem instead of the fundraising narrative.
What Bootstrapping Forced Mochi Health to Get Right
Without a large funding cushion, Mochi didn’t have the option of losing money on every patient while it figured out retention later.
Revenue had to work from day one. This meant that pricing had to be something patients would actually pay and keep paying, not a subsidized rate designed to win a growth metric before the real cost showed up.
That pressure may help explain Mochi’s focus on transparent pricing, with membership and medication costs shown separately rather than combined into a less visible total. That could help patients better understand what they are paying for. Ahmad discussed the importance of clear pricing in a separate HLTH interview.
It also meant retention couldn’t be an afterthought. A company burning venture cash on acquisition can tolerate a fair amount of churn and simply spend to replace it.
A company living on its own revenue can’t. Mochi’s model therefore made patient retention financially important from the beginning. Continuity became central to the platform. Continuity, as in the same provider, the same care team, and an ongoing relationship rather than a one-off prescription. That became the core of the product.
The company had to build a healthcare model patients would want to keep using.
Building a Patient-First Healthcare Model
The same logic extended to how Mochi built its operations. Without a large team funded by outside capital, administrative efficiency had to be engineered into the platform itself rather than solved by hiring.
Ahmad has pointed to operational automation, including AI applied to the administrative side of healthcare, as central to keeping costs down without sacrificing access. She sees artificial intelligence as a way to reduce providers’ administrative burden and free resources for the part of healthcare that requires a human: the provider-patient relationship.
The marketplace structure follows the same constraint. Mochi connects patients, providers, and independent pharmacies through its platform, giving patients greater visibility into treatment and pharmacy choices. This structure is intended to encourage competition in aras such as service and price without requiring Mochi to manage every aspect through additional headcount or overhead.
Every part of the model had to generate its own value immediately, because there was no outside capital standing by to cover the gap if it didn’t.
How Mochi Health Reached More Than 500,000 Patients
Skepticism toward bootstrapping in healthcare usually assumes that only outside capital can fund the infrastructure a real platform needs.
Mochi’s growth challenges that assumption. According to Ahmad’s interview on WoW the company has served more than 500,000 patients while remaining cash-flow-positive. It has also expanded into more than 15 treatment areas covering over 120 conditions.
The broader market is arguably catching up to her bet. As more patients move onto high-deductible plans and are effectively pushed into cash-pay healthcare, a company built from the start around transparent pricing and revenue that has to work on its own terms is positioned exactly where more of the industry is now being forced to go.
What looked like a constraint in 2022 looks, from where the market sits now, like Ahmad started building for today’s healthcare conditions 4 years early.
Photo by Ian Schneider on Unsplash